Search Press releases Keywords From To 22 Nov 2005 Two Senior Pharma Executives as New Members of UCB's Executive Committee Read More 17 Nov 2005 Actelion and UCB enter into assignment and license agreement for Zavesca® (miglustat) Read More 9 Nov 2005 UCB Receives FDA Orphan Drug Designation for Brivaracetam for the Treatment of Symptomatic Myoclonus Read More 27 Oct 2005 UCB Reports Positive Clinical Trial Results for Keppra® as Adjunctive Therapy in the Treatment of Primary Generalised Tonic-Clonic Seizures Read More 20 Oct 2005 UCB confirms good performance of Zyrtec in US and Xyzal Read More 18 Oct 2005 UCB: Phase III study shows CIMZIA(TM) is an effective and well-tolerated treatment for Crohn's disease Read More Pagination First page Previous page Previous … Page 190 Page 191 Page 192 Page 193 Current page 194 Page 195 Page 196 Page 197 Page 198 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
